Home/ Supplements/ Omega 3/ C-Nate DHA

C-Nate DHA

product on market Softgel Capsule Centurion Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 85% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Omega-3 fatty acids and B-complex vitamins are supported by strong evidence for supporting cognitive function and neurological health. These ingredients play key roles in brain structure and energy metabolism. The overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for C-Nate DHA
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
30
Servings
Other Combinations
Product Type
85%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
3 mg
2.5× RDA — within safe limits 76 studies (A:0, B:33)
3 mg
2.3× RDA — within safe limits 13 studies (A:0, B:1)
20 mg
15.4× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
15 mcg
6.2× RDA — above typical dose 139 studies (A:1, B:44)
1 mg
2.5× RDA — within safe limits 226 studies (A:10, B:105)
400 IU
Within RDA (0.7× RDA) 608 studies (A:16, B:251)
Vitamin C
100 mg
30 IU
1.3× RDA — within safe limits 179 studies (A:3, B:90)
1 mg
1.1× RDA — within safe limits 37 studies (A:0, B:11)
20 mg
1.8× RDA — within safe limits 263 studies (A:6, B:134)
Iron
28 mg
30 mg
Within RDA (0.1× RDA) 316 studies (A:8, B:159)
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Dosage and Administration: Usual adult Dose: One softgel daily or as prescribed by your doctor.

Warnings & Precautions

Warning: Accidental overdose of iron-containing products is a leading cause of poisoning of children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Warning: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.

In case of accidental overdose call a doctor or poison control center immediately. Iron is toxic, when overdoses are ingested by children, severe reactions, including fatalities, have resulted. C-Nate DHA should be stored beyond the reach of children to protect against accidental iron poisoning. Keep this and all drugs out of reach of children.

Precautions: Generat Folic acid in doses above 0.1 mg - 0.4 mg daily may obscure pernicious anemia, in that hematologic remission can occur with neurological manifestations remain progressive.

Dispense in a tight, light-resistant container with a child-resistant closure as defined in USP/NF.

Keep this and all drugs out of the reach of children.

Formulation Notes

Indications and Usage: C-Nate DHA is a prescription multivitamin/multimineral indicated for use in improving the nutritional status of woman prior to conception, throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers.

Indications and Usage: C-Nate DHA is a prescription multivitamin/multimineral indicated for use in improving the nutritional status of woman prior to conception, throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers.

Additional Information

See package insert for full prescribing information.

Store at controlled room temperature, 15 - 30 degrees C (59 - 86 degrees F).

NDC 23359-105-30

Rx only

Metadata

Product Details

UPC / SKU3 23359 10530 2
DSLD Entry Date2022-12-13
Product TypeOther Combinations
FormSoftgel Capsule
DSLD ID278706
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.